Structure and total synthesis of lysobactin (katanosin B).
von Nussbaum
Franz
F
Bayer HealthCare AG, Medicinal Chemistry Europe, 42096 Wuppertal, Germany. franz.nussbaum@bayerhealthcare.com
Anlauf
Sonja
S
Benet-Buchholz
Jordi
J
Häbich
Dieter
D
Köbberling
Johannes
J
Musza
László
L
Telser
Joachim
J
Rübsamen-Waigmann
Helga
H
Brunner
Nina A
NA
D002478:Cells, Cultured / Q000187:drug effects; D003500:Cyclization; D047630:Depsipeptides / Q000138:chemical synthesis* / Q000737:chemistry* / Q000494:pharmacology; D013293:Enterococcus faecalis / Q000187:drug effects / Q000254:growth & development; D007769:Lactams / Q000737:chemistry; D008956:Models, Chemical; D010456:Peptides, Cyclic / Q000737:chemistry; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000254:growth & development
D047630:Depsipeptides; D007769:Lactams; D010456:Peptides, Cyclic; C056790:katanosin B